Table 2.
Analysis of factors affecting recipient 6‐month mortality after living‐donor liver transplantation on postoperative day (POD)‐3, ‐7, and ‐14.
| POD‐3 | POD‐7 | POD‐14 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | ||||
| P‐value | OR per SD (95% CI) | P‐value | P‐value | OR per SD (95% CI) | P‐value | P‐value | OR per SD (95% CI) | P‐value | |
| Donor age, years | 1.74 (1.23–2.46) | 0.002 | 1.66 (1.16–2.36) | 0.005 | 1.59 (1.06–2.39) | 0.026 | |||
| Left lobe graft | 2.20 (1.12–4.35) | 0.023 | 1.70 (0.30–3.30) | 0.110 | 1.49 (0.71–3.14) | 0.290 | |||
| HB | 0.980 | 0.470 | 0.230 | ||||||
| PLT | 0.640 | <0.001 | 0.52 (0.31–0.86) | 0.011 | <0.001 | 0.23 (0.09–0.59) | <0.001 | ||
| PT‐INR | <0.001 | 1.28 (0.93–1.75) | 0.130 | <0.001 | 1.60 (1.21–2.12) | <0.001 | <0.001 | 2.18 (1.19–4.01) | 0.007 |
| AST | 0.011 | 1.33 (1.02–1.72) | 0.033 | 0.059 | <0.001 | 1.32 (0.46–3.79) | 0.600 | ||
| ALT | 0.500 | 0.093 | 0.003 | 1.03 (0.40–2.66) | 0.960 | ||||
| T‐Bil | 0.019 | 1.22 (0.87–1.70) | 0.250 | <0.001 | 1.31 (0.96–1.77) | 0.085 | <0.001 | 1.71 (1.21–2.42) | 0.003 |
| ALB | 0.250 | 0.350 | 0.380 | ||||||
| CRE | 0.190 | 0.530 | 0.710 | ||||||
Postoperative prognostic factors were identified each day by univariate analysis then incorporated into the multivariate analysis together with pre‐ and intraoperative prognostic factors identified in Table SS1.
P‐values highlighted in bold are significant. For multivariate analysis, the interaction of each factor was assessed using Spearman's rank correlation coefficient.
ALB, albumin; ALT, alanine transaminase; AST, aspartate aminotransferase; CI, confidence interval; CRE, creatinine; HB, hemoglobin; OR, odds ratio; PLT, platelets; PT‐INR, prothrombin time – international normalized ratio; SD, standard deviation; T‐Bil, total bilirubin.